Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tapentadol”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Large-scale testing (Phase 3)Ended earlyNCT01264887
What this trial is testing

Tapentadol in Chronic Malignant Tumour Related Pain

Who this might be right for
CancerChronic PainPain
Grünenthal GmbH 31
Large-scale testing (Phase 3)Study completedNCT00983385
What this trial is testing

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics

Who this might be right for
Chronic PainLow Back Pain
Grünenthal GmbH 208
Large-scale testing (Phase 3)Study completedNCT02604446
What this trial is testing

Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty.Tapentadol vs Oxycodone vs Placebo

Who this might be right for
Joint Diseases
St. Olavs Hospital 134
Large-scale testing (Phase 3)Study completedNCT01309386
What this trial is testing

A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants

Who this might be right for
Neoplasms
Janssen Pharmaceutical K.K. 100
Large-scale testing (Phase 3)Ended earlyNCT01063868
What this trial is testing

A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)

Who this might be right for
Diabetic Neuropathy, PainfulDiabetic Polyneuropathy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Testing effectiveness (Phase 2)Ended earlyNCT02221674
What this trial is testing

Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old

Who this might be right for
Moderate to Severe Acute Postoperative Pain
Grünenthal GmbH 40
Not applicableUnknownNCT04718116
What this trial is testing

Tapentadol Versus Tramadol Analgesia Post Cardiac Surgery

Who this might be right for
Postoperative PainSurgeryPain, Postoperative+5 more
Aretaieion University Hospital 90
Large-scale testing (Phase 3)Study completedNCT00449176
What this trial is testing

Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain

Who this might be right for
Low Back Pain
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 981
Large-scale testing (Phase 3)Study completedNCT01041859
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy

Who this might be right for
Diabetic Peripheral Neuropathy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 460
Not applicableWithdrawnNCT01719588
What this trial is testing

A Safety and Effectiveness Study of Prolonged Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Chronic Non-Cancer Pain

Who this might be right for
Moderate to Severe Chronic Non-cancer Pain
Janssen Pharmaceutica
Large-scale testing (Phase 3)Study completedNCT00472303
What this trial is testing

Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine

Who this might be right for
TumorPain
Grünenthal GmbH 622
Not applicableStudy completedNCT07320781
What this trial is testing

Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.

Who this might be right for
Breast Cancer
Shaukat Khanum Memorial Cancer Hospital & Research Centre 70
Post-approval studies (Phase 4)Ended earlyNCT01458015
What this trial is testing

Tapentadol Versus Oxycodone - a Mechanism-based Treatment Approach in Neuropathic Pain

Who this might be right for
Peripheral Neuropathy
University Hospital Schleswig-Holstein 3
Large-scale testing (Phase 3)Ended earlyNCT00986258
What this trial is testing

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability

Who this might be right for
PainChronic PainLow Back Pain+2 more
Grünenthal GmbH 136
Large-scale testing (Phase 3)Study completedNCT00478023
What this trial is testing

Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy

Who this might be right for
HysterectomyPostoperative
Grünenthal GmbH 854
Post-approval studies (Phase 4)Study completedNCT03604354
What this trial is testing

Safety and Efficacy of Pre-emptive Tapentadol vs Pregabalin in Post Operative Pain Following Surgery

Who this might be right for
Osteoarthritis, Knee
All India Institute of Medical Sciences, Bhubaneswar 95
Post-approval studies (Phase 4)Study completedNCT01352741
What this trial is testing

Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin

Who this might be right for
Low Back PainNeuropathic Pain
Grünenthal GmbH 622
Large-scale testing (Phase 3)Study completedNCT00983073
What this trial is testing

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular Analgesic

Who this might be right for
Chronic PainOsteoarthritis
Grünenthal GmbH 224
Early research (Phase 1)Study completedNCT01900587
What this trial is testing

A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) Tablet

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 64
Post-approval studies (Phase 4)Study completedNCT01838616
What this trial is testing

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Who this might be right for
Back PainLow Back PainNeuropathic Pain
Grünenthal GmbH 367
Next Page